コンテンツへスキップ
Merck

HAGP1MAG-12K

MILLIPLEX® Human Angiogenesis Panel

Configurable Human Angiogenesis/Growth Factor 17-Plex Panel 1

別名:

human oncology growth factor immunoassay panel, luminex human cancer angiogenesis growth factor multiplex assay, millipore human cancer growth factor protein multiplex kit

ログインで組織・契約価格をご覧ください。

この商品について

UNSPSC Code:
12161503
NACRES:
NA.84
eCl@ss:
32161000

主要文書

すべての文書を表示
テクニカルサービス
お困りのことがあれば、経験豊富なテクニカルサービスチームがお客様をサポートします。
お手伝いします

製品名

MILLIPLEX® Human Angiogenesis Panel, Configurable Human Angiogenesis/Growth Factor 17-Plex Panel 1

species reactivity

human

manufacturer/tradename

Milliplex®

Quality Level

200

packaging

1 ea of

assay range

accuracy: 42-131%
standard curve range: 1.4-1,000 pg/mL
(HB-EGF, IL-8, PLGF)
standard curve range: 13.7-10,000 pg/mL
(Angiopoietin-2, FGF-1, FGF-2, G-CSF, VEGF-A)
standard curve range: 137.2-100,000 pg/mL
(Leptin)
standard curve range: 2.7-2,000 pg/mL
(BMP-9, EGF, Endothelin-1)
standard curve range: 27.4-20,000 pg/mL
(Endoglin, Follistatin, HGF)
standard curve range: 6.9-5,000 pg/mL
(VEGF-C, VEGF-D)

technique(s)

multiplexing: suitable

input

serum plasma (Cell culture, cell culture supernatants)

detection method

fluorometric (Luminex® xMAP® technology)

shipped in

wet ice

storage temp.

2-8°C

関連するカテゴリー

Biochem/physiol Actions

Cross Reactivty
Cross-reactivity between the antibodies and any of the other analytes in this panel is non-detectable or negligible.

Preparation Note

Recommended storage for kit components is 2 - 8°C.

Legal Information

Luminex is a registered trademark of Luminex Corp
MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany
xMAP is a registered trademark of Luminex Corp

Application

MILLIPLEX® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze up to 17 analytes in human serum, plasma, and cell culture supernatants.

Analytes included: Angiopoietin-2, BMP-9, EGF, Endoglin, Endothelin-1, FGF-1 (acidic FGF), FGF-2 (basic FGF), Follistatin, G-CSF, HB-EGF, HGF, IL-8, Leptin, PLGF, VEGF-A, VEGF-C and VEGF-D

Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.

Disclaimer

For research use only. Not for use in diagnostic procedures.Label License/Sticker for Assay Product:By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.

Features and Benefits

  • Comprehensive 17-Biomarker Analysis: This innovative panel enables the simultaneous quantification of 17 critical angiogenesis and growth factor biomarkers, including Angiopoietin-2, BMP-9, EGF, VEGF-A, and more, providing a holistic view of the angiogenic process.
  • Versatile Sample Compatibility: Designed for use with human plasma, serum, tissue/cell lysates, and culture supernatants, offering flexibility for a variety of research applications.
  • Efficient 96-Well Format: Capable of measuring up to 38 samples in duplicate, this format enhances throughput while conserving valuable sample volume, making it ideal for high-volume studies.
  • Luminex® xMAP® Technology: Utilizes a magnetic bead immunoassay format for fast and sensitive quantification of multiple analytes, ensuring high accuracy and efficiency in your research.
  • In-Depth Insights into Angiogenesis: By quantifying multiple biomarkers simultaneously, researchers can gain a deeper understanding of the mechanisms regulating blood vessel formation, which is crucial for studying diseases such as cancer, cardiovascular disorders, and diabetic complications.

General description

Angiogenesis, the development of new vascular networks, is a key process in normal growth and development as well as in wound healing, with homeostasis maintained by a delicate balance of angiogenic factors and inhibitors. Consequently, insufficient, or excessive blood vessel growth underlies many diseases, including cardiovascular disease, diabetic ulcers, macular degeneration, and cancer. Angiogenesis plays a significant role in tumor growth and metastasis.

signalword

Danger

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Sens. 1 - STOT RE 2

target_organs

Respiratory Tract

保管分類

10 - Combustible liquids

wgk

WGK 3

試験成績書（COA）

製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Christopher A Adase et al.
The Journal of biological chemistry, 291(22), 11635-11646 (2016-04-07)
A critical function for skin is that when damaged it must simultaneously identify the nature of the injury, repair barrier function, and limit the intrusion of pathogenic organisms. These needs are carried out through the detection of damage-associated molecular patterns
Neil Patel et al.
American journal of physiology. Lung cellular and molecular physiology, 308(4), L378-L383 (2014-12-07)
Pulmonary hypertension (PH) due to abnormal pulmonary vascular development is an important determinant of illness severity in congenital diaphragmatic hernia (CDH). Vascular endothelial growth factor A (VEGFA) and placental growth factor (PLGF) may be important mediators of pulmonary vascular development
Ruijin Shao et al.
Data in brief, 6, 135-142 (2016-02-10)
In this data, non-pregnant women during the menstrual cycle, women with normal intrauterine pregnancy (IUP), and women with tubal ectopic pregnancy (EP) after informed consent were included. The serum levels of 17β-estradiol, progesterone, testosterone, beta-human chorionic gonadotropin, interleukin (IL)-1β, IL-4
Qing Xu et al.
Journal of diabetes research, 2022, 8435603-8435603 (2022-02-01)
To investigate the aqueous levels of angiogenic factors in nonproliferative diabetic retinopathy (NPDR) patients with diabetic macular edema (DME) and to ascertain their association with optical coherence tomography angiography (OCTA) metrics. This study enrolled 21 NPDR eyes with DME (NPDR/DME+)
Kevin P Daly et al.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 32(1), 120-128 (2012-12-25)
Cardiac allograft vasculopathy (CAV), the major cause of late allograft loss after cardiac transplantation, results from donor-directed cellular and humoral alloimmune responses. Graft vascular endothelial cells (EC) are primary targets of these destructive responses, suggesting that factors associated with endothelial
関連する文献をすべて表示

関連コンテンツ

がん研究のためのマルチプレックスがんアッセイ | MILLIPLEX® アッセイ

MILLIPLEX® マルチプレックスがんアッセイでがんバイオマーカーを検出することにより、腫瘍形成プロセスの研究が加速し、がん研究の進展に役立ちます。

がん・転移におけるシグナル伝達経路のマルチプレックス測定 | MILLIPLEX® アッセイ

MILLPLEXマルチプレックスアッセイで複数の血中バイオマーカーを一度に測定することにより、がん研究を容易にする方法をご覧ください。JAK-STAT、mTOR、MAPK、SAPK、TGFβシグナル伝達経路などを解析するためのマルチプレックスパネルを検索してください。

化粧品とパーソナルケア製品の研究のためのイムノアッセイ

化粧品やパーソナルケア製品の研究において、イムノアッセイを使用して炎症や感作、老化、組織再生に関するバイオマーカーを評価し、化粧品の潜在的な有害作用を調べる方法について紹介します。

MILLIPLEX® PLEXpedition Multiplex Biomarker Screening Panel

Simplify protein biomarker discovery with the MILLIPLEX® PLEXpedition 115-Plex Multiplex Screening Panel. Effortlessly screen cytokines and other markers with Luminex® technology.

すべて表示

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら（テクニカルサービス）